BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $364,343 | +64.5% | 7,997 | +46.5% | 0.02% | +84.6% |
Q1 2023 | $221,458 | -80.0% | 5,460 | -60.3% | 0.01% | -75.5% |
Q3 2020 | $1,105,000 | +2110.0% | 13,737 | +2152.0% | 0.05% | +1666.7% |
Q1 2020 | $50,000 | -92.6% | 610 | -92.4% | 0.00% | -88.5% |
Q4 2019 | $672,000 | -24.6% | 8,034 | -21.1% | 0.03% | -35.0% |
Q3 2019 | $891,000 | +6.5% | 10,187 | -0.4% | 0.04% | -2.4% |
Q2 2019 | $837,000 | +11857.1% | 10,225 | +12681.2% | 0.04% | – |
Q1 2019 | $7,000 | -98.6% | 80 | -99.0% | 0.00% | -100.0% |
Q2 2017 | $503,000 | +218.4% | 8,301 | +172.8% | 0.05% | +220.0% |
Q1 2017 | $158,000 | +315.8% | 3,043 | +252.6% | 0.02% | +200.0% |
Q4 2016 | $38,000 | -90.2% | 863 | -89.4% | 0.01% | -87.8% |
Q3 2016 | $388,000 | -20.2% | 8,160 | -24.1% | 0.04% | -39.7% |
Q2 2016 | $486,000 | +575.0% | 10,758 | +514.0% | 0.07% | +580.0% |
Q1 2016 | $72,000 | -85.6% | 1,752 | -88.5% | 0.01% | -86.3% |
Q3 2015 | $499,000 | +667.7% | 15,200 | +1506.8% | 0.07% | +711.1% |
Q1 2015 | $65,000 | -5.8% | 946 | -1.5% | 0.01% | -10.0% |
Q3 2014 | $69,000 | +50.0% | 960 | +51.9% | 0.01% | +66.7% |
Q2 2014 | $46,000 | -57.0% | 632 | -56.7% | 0.01% | -57.1% |
Q1 2014 | $107,000 | -38.5% | 1,458 | -41.7% | 0.01% | -51.7% |
Q4 2013 | $174,000 | +3380.0% | 2,500 | +3025.0% | 0.03% | +2800.0% |
Q3 2013 | $5,000 | – | 80 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |